Quantcast
Home > Quotes > CPHI

China Pharma Holdings, Inc. Common Stock (CPHI) Quote & Summary Data

CPHI 
$0.3576
*  
0.0024
0.67%
Get CPHI Alerts
*Delayed - data as of Nov. 14, 2018 10:50 ET  -  Find a broker to begin trading CPHI now
Exchange:AMEX
Industry: Health Care
Community Rating:
View:    CPHI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
Today's High / Low
$ 0.372 / $ 0.34
Share Volume
244,281
90 Day Avg. Daily Volume
751,138
Previous Close
$ 0.36
52 Week High / Low
$ 1.45 / $ 0.16
Market Cap
15,584,050
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.02

Intraday Chart

Shares Traded

Share Volume:
244,281
90 Day Avg. Daily Volume:
751,138

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.40

Trading Range

The current last sale of $0.3576 is 123.50% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.372 $ 1.45
 Low: $ 0.34 $ 0.16

Company Description (as filed with the SEC)

We are principally engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China (the "PRC"). All of our operations are conducted in the PRC, where our manufacturing facilities are located. We manufacture pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The majority of our pharmaceutical products are sold on a prescription basis and all have been approved for at least one or more therapeutic indications by the China Food and Drug Administration (the "CFDA") based upon demonstrated safety and efficacy.  ... More ...  

Research Brokers before you trade

Want to trade FX?

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x